Latest News & Features
Big Pharma
Pharmaceutical company Recordati suffered a setback last week after the EU General Court dismissed its appeal over a trademark registration. 12 March 2018
Americas
Japanese pharmaceutical company Eisai has teamed up with US-based Merck in a deal intended to strengthen the worldwide development and commercialisation of cancer drug Lenvima. 9 March 2018
Big Pharma
European Council president Donald Tusk appears to have shot down the possibility of the UK remaining part of some EU agencies, including the European Medicines Agency (EMA), after Brexit. 8 March 2018
Big Pharma
The German Federal Patent Court has set aside a decision by the German Patent and Trade Mark Office to reject a supplementary protection certificatesupplementary protection certificate that GSK Biologicals had applied for, in a decision of “fundamental importance”. 8 March 2018
Americas
The IP team at AstraZeneca must “ruthlessly” prioritise how it spends time and resources, its vice president of global IP explained in an interview. 8 March 2018
Europe
The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology. 7 March 2018
Americas
AstraZeneca’s research development arm MedImmune has revealed plans to spin out six molecules into an independent biotech company. 6 March 2018
Americas
Mylan has revealed plans to develop and commercialise a proposed biosimilar to Botox. 6 March 2018
Americas
The financial stakes in the biosimilars market are enormous, and an understanding of sequence IP for the underlying technologies and modes of action is key to entry into it, say Henk Heus and Ellen Sherin of GQ Life Sciences. 6 March 2018
Big Pharma
The UK’s Prime Minister has revealed that the UK would be willing to remain part of the European Medicines Agency after Brexit. 5 March 2018